The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures (Q34938339)

5 August 2017

1 reference

title

The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures (English)

1 reference

5 August 2017

1 reference

Janine Nuver

1

1 reference

5 August 2017

Andries J Smit

2

1 reference

5 August 2017

Aleida Postma

3

1 reference

5 August 2017

Dirk Th Sleijfer

4

1 reference

5 August 2017

Jourik A Gietema

5

1 reference

5 August 2017

1 August 2002

1 reference

5 August 2017

Cancer Treatment Reviews

1 reference

5 August 2017

28

1 reference

5 August 2017

4

1 reference

5 August 2017

195-214

1 reference

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Late deaths and survival after childhood cancer: implications for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Late mortality of long-term survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Death during adulthood in survivors of childhood and adolescent cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Late deaths after treatment for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Insulin resistance syndrome and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Syndrome X: 10 years after

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endothelial dysfunction: cause of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The adrenal and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Childhood cancer and later development of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrine late effects of childhood cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrine consequences of treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Growth and growth hormone status following treatment for childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Usefulness of sex steroid hormone levels in predicting coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effect of obesity and body fat distribution on sex hormones and insulin in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The effects of testosterone on insulin sensitivity in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Testosterone concentrations in women and men with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endogenous sex hormone levels in older adult men with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Hypogonadism and androgen replacement therapy in elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Functional cardiac disturbances related to chemotherapy independent of anthracycline use in children with neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effects of long-term use of testosterone enanthate. II. Effects on lipids, high and low density lipoprotein cholesterol and liver function parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Testosterone propionate therapy in one hundred cases of angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Acute anti-ischemic effect of testosterone in men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrinological late effects after chemotherapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Castration and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Estrogen replacement and brachial artery flow-mediated vasodilation in older women.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Hormone replacement therapy, heart disease, and other considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Ovarian function after bone marrow transplantation during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Factors affecting gonadal function after bone marrow transplantation during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Abdominal obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Growth hormone corrects vascular dysfunction in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Abnormal vascular reactivity in growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Reduced growth hormone secretion with maintained periodicity following cranial irradiation in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Toxicities of total-body irradiation for pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cardiovascular risk factors in adult patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thyroid disease and its treatment: short-term and long-term cardiovascular consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cardiovascular and atherogenic aspects of subclinical hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The treatment of subclinical hypothyroidism is seldom necessary

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thyroid dysfunction following radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term complications of total body irradiation in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endocrine deficit after fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thyroid dysfunction among long-term survivors of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

SEVERE HYPOTHYROIDISM AFTER CHEMOTHERAPY AND LOCOREGIONAL IRRADIATION FOR BREAST CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Tamoxifen, serum lipoproteins and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thyroid function after postoperative radiation therapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium and phosphorus.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Model of cardiovascular injury in magnesium deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium and phosphorus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium deficiency produces insulin resistance and increased thromboxane synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Magnesium and trace metals: risk factors for coronary heart disease? Association between blood levels and angiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Dietary calcium, potassium, magnesium and blood pressure in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Relation of electrolytes to blood pressure in men. The Yi people study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

A prospective study of nutritional factors and hypertension among US women

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

A prospective study of nutritional factors and hypertension among US men

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Platinum organ toxicity and possible prevention in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Radiation injury to the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Partial reversibility of cisplatin nephrotoxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term renal function after treatment for malignant germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Early anthracycline cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Severe vascular toxicity associated with cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Angina pectoris following cisplatin, etoposide, and bleomycin in a patient with advanced testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Fatal cerebrovascular accident associated with chemotherapy for testicular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Vascular toxicity associated with antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Release of cytokines from human umbilical vein endothelial cells treated with platinum compounds in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Vitamin E prevents endothelial injury associated with cisplatin injection into the superior mesenteric artery of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

In vitro toxicity studies with mitomycins and bleomycin on endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Bleomycin stimulates production of transforming growth factor-beta by rat pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Improved endothelial function with metformin in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Lifestyle intervention in overweight individuals with a family history of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900038-5

7 January 2021

10.1016/S0305-7372(02)00038-5

Identifiers

DOI

1 reference

5 August 2017

1 reference